ARJUNA Therapeutics
We are develpoing a new class of small molecules to tackle untreatable cancer.
Status
IP Type
Patent
Time
–
Countries
Coverage
Manufacturing, therapeutic use as single agent or in combination for cancer and some non-cancer indications.
This information is confidential, do not share or copy.
You can visit their website or
Under evaluation at least till: May 8th, 2022
KEEP REVIEWING